isto
-
Biologics
Isto Biologics will join industry experts at the annual North American Spine Society (NASS) meeting in Boston this week
ST. LOUIS, Oct. 25, 2016 /PRNewswire/ — Isto Biologics is wasting no time in showcasing its bone-regeneration technologies and cell-based therapy to…
Read More » -
Biologics
Isto and Arteriocyte join forces to form leading biologics player, Isto Biologics
ST. LOUIS, Oct. 19, 2016 /PRNewswire/ — Isto Holdings, the parent company of St. Louis-based Isto Technologies – a leader in bone-regeneration technologies and…
Read More » -
Financial
Thompson Street Capital Partners Acquires Isto Technologies’ Commercial Business
ST. LOUIS (June 3, 2016) – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis with…
Read More » -
ISTO assumes full control of Zimmer cartilage implant
ISTO Technologies Inc. announced an agreement with Zimmer Holdings Inc. giving ISTO full control of the DeNovo ET Engineered Tissue…
Read More » -
ISTO Technologies Awarded Key Patent for NuQu™ Injectable Therapy for Degenerative Disc Disease
ST. LOUIS, Feb. 7, 2011 /PRNewswire/ — ISTO Technologies, Inc. announced today that the United States Patent and Trademark Office (USPTO) has…
Read More » -
ISTO Technologies Inc. to Present at the Canaccord Adams Musculoskeletal Conference
ST. LOUIS, MO–(Marketwire – February 16, 2010) – ISTO Technologies, Inc. announced today that it will participate in the 2010…
Read More »